Unresolved disorder model. using A
ATOM    864  SG ACYS   118      -2.215  39.766  20.415  1.00 48.17           S  
Unresolved disorder model. using A
ATOM    975  CG AGLN   131       3.466  22.976  15.742  1.00 44.85           C  
Unresolved disorder model. using A
ATOM    976  CD AGLN   131       3.991  22.781  17.191  1.00 44.55           C  
Unresolved disorder model. using A
ATOM    977  OE1AGLN   131       3.552  23.428  18.117  1.00 43.18           O  
Unresolved disorder model. using A
ATOM    978  NE2AGLN   131       4.935  21.856  17.363  1.00 46.64           N  
Unresolved disorder model. using A
ATOM   1670  N  AMET   233      -9.200  25.241  43.315  0.50 51.35           N  
Unresolved disorder model. using A
ATOM   1671  CA AMET   233      -9.474  25.233  41.880  0.50 51.37           C  
Unresolved disorder model. using A
ATOM   1672  C  AMET   233     -10.070  23.881  41.446  0.50 50.98           C  
Unresolved disorder model. using A
ATOM   1673  O  AMET   233      -9.672  22.831  41.961  0.50 50.99           O  
Unresolved disorder model. using A
ATOM   1674  CB AMET   233      -8.219  25.573  41.073  0.50 51.47           C  
Unresolved disorder model. using A
ATOM   1675  CG AMET   233      -7.953  27.074  41.012  0.50 51.94           C  
Unresolved disorder model. using A
ATOM   1676  SD AMET   233      -7.224  27.598  39.458  0.50 53.07           S  
Unresolved disorder model. using A
ATOM   1677  CE AMET   233      -5.718  26.639  39.462  0.50 53.32           C  
Unresolved disorder model. using A
ATOM   1678  N  BMET   233      -9.190  25.237  43.329  0.50 51.08           N  
Unresolved disorder model. using A
ATOM   1679  CA BMET   233      -9.454  25.141  41.902  0.50 50.91           C  
Unresolved disorder model. using A
ATOM   1680  C  BMET   233     -10.260  23.886  41.599  0.50 50.72           C  
Unresolved disorder model. using A
ATOM   1681  O  BMET   233     -10.192  22.910  42.351  0.50 50.73           O  
Unresolved disorder model. using A
ATOM   1682  CB BMET   233      -8.160  25.106  41.102  0.50 50.67           C  
Unresolved disorder model. using A
ATOM   1683  CG BMET   233      -7.858  26.424  40.454  0.50 50.34           C  
Unresolved disorder model. using A
ATOM   1684  SD BMET   233      -6.142  26.824  40.667  0.50 49.16           S  
Unresolved disorder model. using A
ATOM   1685  CE BMET   233      -6.215  28.612  40.528  0.50 49.82           C  
Unresolved disorder model. using A
ATOM   1814  CG APHE   248      14.616  27.928  36.856  1.00 61.91           C  
Unresolved disorder model. using A
ATOM   1815  CD1APHE   248      14.337  28.458  35.618  1.00 61.69           C  
Unresolved disorder model. using A
ATOM   1816  CD2APHE   248      13.577  27.420  37.613  1.00 63.10           C  
Unresolved disorder model. using A
ATOM   1817  CE1APHE   248      13.046  28.511  35.158  1.00 62.22           C  
Unresolved disorder model. using A
ATOM   1818  CE2APHE   248      12.281  27.480  37.155  1.00 63.03           C  
Unresolved disorder model. using A
ATOM   1819  CZ APHE   248      12.018  28.028  35.920  1.00 62.28           C  
Unresolved disorder model. using A
ATOM   1884  CG AGLU   257      21.876  35.053  37.354  1.00 43.26           C  
Unresolved disorder model. using A
ATOM   1885  CD AGLU   257      21.948  33.611  37.811  1.00 44.29           C  
Unresolved disorder model. using A
ATOM   1886  OE1AGLU   257      23.035  33.009  37.737  1.00 45.64           O  
Unresolved disorder model. using A
ATOM   1887  OE2AGLU   257      20.910  33.081  38.245  1.00 44.91           O  

1